Original Research ArticleInternational Journal of Research in Orthopaedics

Publication:
Role of platelet-rich plasma in treating chronic tendinopathies

Int J Res Orthop. 2026;12(3):637-640.DOI10.18203/issn.2455-4510.IntJResOrthop20261067

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Background Chronic tendinopathies often result in musculoskeletal pain and functional limitations, typically refractory to conventional conservative treatments. Platelet-rich plasma (PRP) therapy has emerged as a biologically derived strategy aimed at enhancing tendon healing through the provision of growth factors and cytokines.

Methods This forward-looking multicentric study took place at VIMSAR Burla, FMCH Balasore, and GMC Sundargarh from December 2023 to December 2025. The study included 200 to 250 individuals with chronic tendinopathies. Patients received ultrasound-guided PRP injections and were then examined at regular intervals for pain relief and functional improvement.

Results Patients saw a considerable improvement in both their pain scores and their ability to do things after PRP therapy. Most of them showed continuing clinical improvement during follow-up, with few issues.

Conclusions PRP is a safe and effective way to treat chronic tendinopathies. It can help with pain and getting back to normal.

Keywords

Affiliations

  1. Department of Orthopaedic, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, Odisha, India
  2. Department of Orthopaedic, FM Medical College and Hospital, Balasore, Odisha, India
  3. Department of Orthopaedic, Government Medical College, Sundergarh, Odisha, India

Full item record